NEO logo

NEO NeoGenomics, Inc.

NASDAQ Capital Market · Medical - Diagnostics & Research · Healthcare

$14.82
-0.27 (-1.79%)

NeoGenomics, Inc. specializes in providing cancer-focused diagnostic and testing services through an extensive network of laboratories located across the United States, Europe, and Asia. The company operates through two distinct divisions: Clinical Services and Pharma Services. Its comprehensive offerings cater to a diverse clientele, including hospitals, reference laboratories, pathologists, onco…

Market Cap: $1.93Bwww.neogenomics.com

Price

No data yet.

Social Signal Score

36
5d
20
2 mentions
—
30d
40
7 mentions
—
60d
42
14 mentions
—
90d
44
19 mentions
—
news: 19

Analyst Ratings

30 analysts
Buyconsensus
Strong Buy 1Buy 23Hold 5Sell 1Strong Sell 0
Avg price target$22.6+52.5%
Low $19Median $22High $28
Current Consensus

Revenue

$209.25M+245.93%
$60.49M$110.08M$159.67M$209.25M
Dec 2016Sep 2026

Analyst Estimates

FY2025
$0.09
$0.08–$0.11
8 analysts
FY2026
$0.20+118% YoY
$0.19–$0.21
6 analysts
FY2027
$0.31+53% YoY
$0.30–$0.33
7 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Anthony Zook
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Employees
2,500
Beta
1.83
Country
US
Piotroski score
4 / 9 (Middling)
Altman Z-score
2.29
www.neogenomics.com